Monday, 19 August 2019

FDA approves Nabriva's antibiotic for pneumonia

The U.S. Food and Drug Administration on Monday approved Nabriva Therapeutics Plc's antibiotic Xenleta for treating patients with community-acquired pneumonia.


No comments:

Post a Comment